IA
KRYS icon

IFP Advisors’s Krystal Biotech KRYS Stock Holding History

IFP Advisors’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$16.8K Sell
65
-200
-75% -$53.2K ﹤0.01% 2865
2025
Q4 		$65.3K Buy
265
+189
+249% +$39.8K ﹤0.01% 2038
2025
Q3 		$13.4K Buy
76
+66
+660% +$9.88K ﹤0.01% 2761
2025
Q2 		$1.37K Buy
+10
New +$1.47K ﹤0.01% 4074
2024
Q2 		– Sell
-267
Closed -$47.3K – 3288
2024
Q1 		$47.3K Buy
267
+7
+3% +$972 ﹤0.01% 1614
2023
Q4 		$32.2K Buy
260
+229
+739% +$25.4K ﹤0.01% 1730
2023
Q3 		$3.6K Buy
+31
New +$3.78K ﹤0.01% 2637
2021
Q3 		– Hold
0
– – – 4085
2021
Q2 		– Hold
0
– – – 3814
2021
Q1 		– Hold
0
– – – 3736
2020
Q4 		– Hold
0
– – – 3580
2020
Q3 		– Hold
0
– – – 3456

Other funds holding KRYS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return